Novo Nordisk hires US pharma veteran as Trump pricing pressure mounts
Reuters
Oct 17
<a href="https://laohu8.com/S/NVO">Novo Nordisk</a> hires US pharma veteran as Trump pricing pressure mounts
LONDON/COPENHAGEN, Oct 17 (Reuters) - Novo Nordisk NOVOb.CO has appointed U.S. pharmaceutical executive Greg Miley as its new head of corporate affairs, according to a statement he posted on LinkedIn, as the obesity drugmaker faces growing pressure from the Trump administration on drug pricing.
Miley, an American, is currently senior vice president of government affairs at U.S. pharmaceutical giant AbbVie ABBV.N. He posted the statement on LinkedIn on Friday and Novo Nordisk shared the statement with Reuters.
(Reporting by Maggie Fick in London and Stine Jacobsen in Copenhagen, Editing by Louise Heavens)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.